| Net Cash Provided by (Used in) Operating Activities |
$13,782,000 |
USD |
107% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,560,000 |
USD |
-57% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$18,911,000 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
40,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
18,337,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,059,000 |
USD |
-20% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$3,365,000 |
USD |
-15% |
Q1 2025 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability |
$2,600,000 |
USD |
-19% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$26,591,000 |
USD |
7.8% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$14,389,000 |
USD |
-41% |
Q1 2024 |
Q1 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$3,700,000 |
USD |
-20% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$600,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$900,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$800,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$1,382,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,100,000 |
USD |
-21% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$900,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
13,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
120,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$900,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
16,000 |
shares |
-20% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$5,979,000 |
USD |
-17% |
Q1 2024 |
Q1 2024 |
| Interest Expense |
$14,500,000 |
USD |
19% |
Q3 2024 |
Q3 2024 |